Improving treatment for opioid and polysubstance use in primary care.
MANAGEMENT OF UNHEALTHY OPIOID AND POLYSUBSTANCE USE AMONG PATIENTS IN PRIMARY CARE SETTING. 09/01/2022 - 08/14/2027. N01DA-19-2250. TASK ORDER 75N950
['FUNDING_OTHER'] · THE EMMES COMPANY, LLC · NIH-10696444
This study is looking for better ways to help people who are dealing with opioid and other substance use issues in their regular doctor’s office, so they can get the support they need more easily.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | THE EMMES COMPANY, LLC (nih funded) |
| Locations | 1 site (ROCKVILLE, UNITED STATES) |
| Trial ID | NIH-10696444 on ClinicalTrials.gov |
What this research studies
This research aims to enhance the management of opioid and polysubstance use among patients in primary care settings. It is part of the NIH's HEAL initiative, which focuses on finding effective solutions to the opioid crisis. The approach involves developing and testing new treatment strategies that can be implemented in everyday healthcare environments, making it easier for patients to receive the help they need. By building a solid evidence base, the research seeks to improve outcomes for individuals struggling with addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are experiencing issues with opioid or polysubstance use and are seeking treatment in a primary care setting.
Not a fit: Patients who are not struggling with substance use disorders or those who are not seeking treatment in primary care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients dealing with opioid and polysubstance use disorders.
How similar studies have performed: Previous research under the HEAL initiative has shown promise in developing effective strategies for addressing opioid misuse, indicating that this approach is building on successful methodologies.
Where this research is happening
ROCKVILLE, UNITED STATES
- THE EMMES COMPANY, LLC — ROCKVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MCCORMACK, JENNIFER — THE EMMES COMPANY, LLC
- Study coordinator: MCCORMACK, JENNIFER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.